AHN Allegheny General Hospital is a clinical research site located in Pittsburgh, Pennsylvania, United States 15212.
Crixeo Clinical Trials Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.
AHN Allegheny General Hospital has participated in 22 clinical trials with 16 currently active.
Therapeutic areas: Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a), Breast Cancer.
Sponsors: Eli Lilly and Company, Merck Sharp & Dohme LLC, Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute).
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Pennsylvania · View every site in Pittsburgh
Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
AHN Allegheny General Hospital has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
AHN Allegheny General Hospital has 22 clinical trials on record, with 16 currently active. Their work covers Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a), Breast Cancer.
AHN Allegheny General Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.